Drug · DIN 02451611
KOVALTRY
SUPPLIED WITH BIO-SET. KIT CONTAINING: A) SINGLE-USE VIAL AND B) DILUENT (2.5 ML PREFILLED SYRINGE)
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 30, 2018.
- Drug Identification Number (DIN)
- 02451611
- Company (DIN owner)
- Bayer Inc.Elkhart, Indiana, United States
- Schedule
- Schedule D
- Dosage form
- Kit; Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Coagulation factor viii B02BD02
- Class
- Human
- Record last updated
- September 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 500 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 27, 2016: NOC 17727New Drug Submission (NDS)
Other DINs named KOVALTRY
- DIN 02451441 · Marketed
- DIN 02451468 · Marketed
- DIN 02451476 · Marketed
- DIN 02451484 · Marketed
- DIN 02451492 · Marketed
- DIN 02451603 · Cancelled Pre Market
- DIN 02451638 · Cancelled Pre Market
- DIN 02451646 · Cancelled Pre Market
- DIN 02451654 · Cancelled Pre Market